Overexpression of the platelet P2X1 ion channel in transgenic mice generates a novel prothrombotic phenotype
Open Access
- 15 May 2003
- journal article
- Published by American Society of Hematology in Blood
- Vol. 101 (10) , 3969-3976
Abstract
We have generated transgenic mice overexpressing the human P2X1 ion channel in the megakaryocytic cell lineage. Platelets from transgenic mice exhibited a gain of P2X1ionotropic activity as determined by more prominent P2X1-mediated Ca2+ influx and platelet shape change. P2X1 overexpression enhanced platelet secretion and aggregation evoked by low doses of collagen, convulxin, or the thromboxane A2 mimetic U46619. In contrast, transgenic platelet responses to adenosine diphosphate (ADP) or thrombin were normal. Perfusing whole blood from transgenic mice over collagen fibers at a shear rate of 1000 seconds−1 resulted in increased P2X1-dependent aggregate formation and phosphatidylserine exposure. Platelet hyperreactivity to collagen was correlated with up-regulated extracellular signal-regulated kinase 2 (ERK2) phosphorylation. Accordingly, the MEK1/2 inhibitor U0126 potently inhibited the collagen-induced aggregation of transgenic platelets when stirred or when perfused over a collagen surface. In a viscometer, shear stress caused potent aggregation of transgenic platelets under conditions in which wild-type platelets did not aggregate. In an in vivo model of thromboembolism consisting of intravenous injection of a low dose of collagen plus epinephrine, transgenic mice died more readily than wild-type mice. Preinjection of U0126 not only fully protected transgenic mice against thrombosis, it also enhanced the survival of wild-type mice injected with a higher collagen dose. Hence, the platelet P2X1 ion channel plays a role in hemostasis and thrombosis through its participation in collagen-, thromboxane A2-, and shear stress–triggered platelet responses. Activation of the ERK2 pathway is instrumental in these processes.Keywords
This publication has 33 references indexed in Scilit:
- Molecular Physiology of P2X ReceptorsPhysiological Reviews, 2002
- Potential therapeutic targets in the rapidly expanding field of purinergic signallingClinical Medicine, 2002
- Platelet Shape Change Evoked by Selective Activation of P2X1 Purinoceptors with α,β-Methylene ATPThrombosis and Haemostasis, 2001
- ADP Receptors of Platelets and their InhibitionThrombosis and Haemostasis, 2001
- ADP is not an agonist at P2X1 receptors: evidence for separate receptors stimulated by ATP and ADP on human plateletsBritish Journal of Pharmacology, 2000
- Characterization of P2x1 purinoreceptors on rat platelets: effect of clopidogrel.British Journal of Haematology, 1997
- P2X Receptors: An Emerging Channel FamilyEuropean Journal of Neuroscience, 1996
- Activation of Receptor-operated Cation Channels via P2X1 Not P2T Purinoceptors in Human PlateletsJournal of Biological Chemistry, 1996
- Purinoceptors: Are there families of P2X and P2Y purinoceptors?Pharmacology & Therapeutics, 1994
- Adenine Nucleotides in Blood Platelets1985